Answers are grounded in this paper and cite their sources.
Ectopic pregnancy is an important cause of maternal morbidity in early pregnancy. Single-dose methotrexate is commonly used for haemodynamically stable women with unruptured tubal ectopic pregnancy, but treatment success varies. The association between pre-treatment endometrial ultrasonographic features and treatment outcome remains uncertain. This prospective case series included 177 women with confirmed tubal ectopic pregnancy who received a single intramuscular dose of methotrexate (50 mg/m2) at two tertiary hospitals in Isfahan, Iran, between January and December 2024. Transvaginal ultrasonography was used to measure endometrial thickness and classify the endometrial echo pattern as homogeneous or triple-layer. Treatment success was defined as a ≥ 15% decline in serum β-hCG from day 4 to day 7 after treatment, followed by weekly monitoring until the concentration became undetectable. Associations with treatment success were assessed using univariable logistic regression. Treatment success occurred in 94 of 177 women (53.1%). Responders had lower median baseline β-hCG concentrations (500 versus 1400 mIU/mL; P < 0.001), thinner endometrium (7 versus 9 mm; P = 0.009), and a higher proportion of homogeneous endometrial appearance (65.9 versus 49.4%; P = 0.026). In univariable logistic regression, baseline β-hCG (P = 0.003), ectopic pregnancy size (P = 0.013), and homogeneous endometrial appearance (P = 0.027) were significantly associated with treatment success; endometrial thickness showed borderline evidence of association (P = 0.0498). Baseline β-hCG, ectopic pregnancy size, and endometrial appearance were associated with single-dose methotrexate success in univariable analyses, while endometrial thickness showed a borderline association. Because no multivariable model was fitted, these findings should not be interpreted as independent predictors. Endometrial ultrasonographic features may provide supportive information alongside established clinical factors such as baseline β-hCG. Ectopic pregnancy happens when a fertilised egg grows outside the womb, usually in a fallopian tube. This condition can be dangerous and needs quick treatment. In many cases, doctors can treat it with a medicine called methotrexate instead of surgery, but the medicine does not always work. In this study, we followed 177 women with a tubal ectopic pregnancy who were treated with one dose of methotrexate. We examined whether ultrasound features of the lining of the womb (the endometrium), together with other baseline clinical findings, were associated with whether treatment worked. Just over half of the women (53 out of every 100) were successfully treated with the single dose. Women with successful treatment had lower pregnancy-hormone levels, a thinner womb lining, and more often had a homogeneous endometrial appearance. When each baseline factor was examined separately, the pregnancy-hormone level, ectopic pregnancy size, and endometrial appearance were significantly associated with treatment success; endometrial thickness was borderline. The study examined these factors one at a time and therefore cannot show which factor predicts success independently of the others. Blood β-hCG remains an established part of clinical assessment, while ultrasound features of the endometrium may provide additional supportive information and should be interpreted together with the full clinical picture.
No takes yet. Share an insight, caveat, or question.
Shirazinezhad et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: